about
CD20 deficiency in humans results in impaired T cell-independent antibody responsesClonally-related immunoglobulin VH domains and nonrandom use of DH gene segments in rheumatoid arthritis synoviumFrequent T and B cell oligoclones in histologically and immunophenotypically characterized angioimmunoblastic lymphadenopathyLack of allelic exclusion in B cell chronic lymphocytic leukemiaQuantitative and qualitative changes in V-J alpha rearrangements during mouse thymocytes differentiation: implication for a limited T cell receptor alpha chain repertoireB cells in rheumatoid arthritisHuman antibody production in transgenic animalsImmunoglobulin Gene Mutations and Frequent Use of VH1-69 and VH4-34 Segments in Hepatitis C Virus-Positive and Hepatitis C Virus-Negative Nodal Marginal Zone B-Cell LymphomaOne-megabase sequence analysis of the human immunoglobulin lambda gene locusVH3 gene usage in neutralizing human antibodies specific for the Entamoeba histolytica Gal/GalNAc lectin heavy subunitPlatelet alphaIIbbeta3 recombinant autoantibodies from the B-cell repertoire of a post-transfusion purpura patient.Laser-capture microdissection of plasma cells from subacute sclerosing panencephalitis brain reveals intrathecal disease-relevant antibodiesIntroduction to antibody engineering and phage display.The isolation and characterisation of human monoclonal HLA-A2 antibodies from an immune V gene phage display library.The role of somatic mutation in determining the affinity of anti-DNA antibodies.Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display.Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation.Simian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: recovery from a long-term-nonprogressor SIV-infected macaque.Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein.Molecular studies of anti-HLA-A2 using light-chain shuffling: a structural model for HLA antibody binding.Isolation of monomeric human V(H)s by a phage selection.Molecular characterization of the variable domains of an alphaIIbbeta3-specific immunoglobulin M kappa platelet cold agglutinin in a follicular lymphoma patient with treatment refractory autoimmune thrombocytopenia: idiotypic overlap between alphaIIIsolation of human single chain variable fragment antibodies against specific sperm antigens for immunocontraceptive development.The isolation and characterisation of antiplatelet antibodies.Critical epitopes in the nucleocapsid protein of SFTS virus recognized by a panel of SFTS patients derived human monoclonal antibodiesNontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice.Biased use of the IGHV4 family and evidence for antigen selection in Chlamydophila psittaci-negative ocular adnexal extranodal marginal zone lymphomas.The immunoglobulin heavy chain locus: genetic variation, missing data, and implications for human disease.Human monoclonal antibody to hepatitis C virus E1 glycoprotein that blocks virus attachment and viral infectivityChimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus.Staphylococcus aureus infection induces protein A-mediated immune evasion in humans.Automated cleaning and pre-processing of immunoglobulin gene sequences from high-throughput sequencing.Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosisT(11;18)(q21;q21)-positive gastrointestinal MALT lymphomas are heterogeneous with respect to the V(H) gene mutation status.Molecular characterization of the cervical and systemic B-cell repertoire: Unique, yet overlapping, immune compartments of an HIV-1 resistant individual.ATM mutations in sporadic lymphoid tumours.Minimal disease assessment in the treatment of children and adolescents with intermediate-risk (Stage III/IV) B-cell non-Hodgkin lymphoma: a children's oncology group report.Genetic diversity of the human immunoglobulin heavy chain VH region.Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis opticaPhage antibody display libraries: a powerful antibody discovery platform for immunotherapy.
P2860
Q24653638-25B34C57-CE5F-42CA-AF45-2BB35BD057ACQ24654191-B70416C4-B086-4D82-B777-9D26BE0AB4E4Q24669746-A17421A1-F4B1-4AF0-BDE0-B3280AD8BBDFQ24669832-6002E10B-4ECF-4D2F-8039-8457971641CFQ24673005-BCF5E6AA-DABF-4CF9-B677-2364B61847F1Q24806825-E5CBC1EA-FD9A-4D7B-9DC0-14CCB1E7623CQ27023477-EEA462F8-B05E-4A52-A784-3950776D245BQ27478232-41EBE863-F538-4EFB-88C8-A8846CB52BC1Q28306323-36FEBEF7-E68D-487D-97FE-D12FC4B83D3DQ30452770-A325F8DD-61CB-4A6B-9DBD-1CE24BC5E5E2Q30724883-06CEDC89-2BEF-4846-AA8F-406AC9DE3B86Q30851947-C93B8746-05BD-4E9D-963A-DAFD05B507D2Q30857843-B066E61C-1561-4D59-A851-94E79C4B20D3Q30860547-F83E02F1-6E1B-43A7-A70A-58043CCD9066Q31125361-A6779444-C4DF-4BE0-9EB5-E3528BD603ACQ31161442-D657508E-C78C-497C-AF88-B719765672BBQ31977172-8DD7C8E3-A797-4E10-A1E1-A48EF9ABFF72Q32157141-BB05526D-F900-4006-82BF-BE1C36E3EB9EQ33180421-C19E453D-7BE0-415A-A2AA-B3715A1BFEA4Q33199161-DFEA6EAA-E93D-47E2-80B8-51E5E7481606Q33225080-1A2D6F56-5989-4753-A211-A9B226752274Q33275315-6E1442D5-E920-41D4-BB3C-9F0E62E1CC75Q33326086-440F81EE-248B-4B62-B203-3C10B442B991Q33370444-3188B62C-B3C0-4A2C-8AC6-502AF4D9780EQ33401906-D2F8C173-58F8-4707-A645-443211B07D1EQ34096536-06F1937D-86AE-4AA8-A292-6355B23EEA45Q34117217-7E241A42-1040-4AD2-A807-EC992AF6FCC4Q34253950-8FD459A2-4EF5-4894-BDB0-1FDCE6B951F3Q34437763-1477BE64-371D-4362-B85E-5B37F71D3B81Q34478724-423A52E6-36DB-4449-AAB9-C4D973C64916Q34533083-94B0B41A-12A6-433A-B14C-1E179F3DA207Q34537815-F6B94996-9D88-40A9-BD70-17CD14698702Q34538912-AA930FF4-44C1-42A6-A1B3-FEBA0223E820Q34612166-3827D5A0-D6B2-4C07-BA66-069345912F35Q34974782-E5F25774-17BB-4863-AB8E-611DCA3A2C5CQ34980360-18FBE1D1-A9BA-4315-8F28-01F0A3F7A55BQ35011933-49C63DE6-2E72-4BAC-B522-8FB51471DCC3Q35030955-BA2726B3-BE2C-4F63-85F0-094F918B0DF0Q35234452-C7176FAD-B17A-4DBC-BA4A-EBF87358C745Q35419158-FEAB44B4-78E5-4386-90C9-06BEAD46B454
P2860
description
1995 nî lūn-bûn
@nan
1995 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
The human immunoglobulin VH repertoire.
@ast
The human immunoglobulin VH repertoire.
@en
The human immunoglobulin VH repertoire.
@nl
type
label
The human immunoglobulin VH repertoire.
@ast
The human immunoglobulin VH repertoire.
@en
The human immunoglobulin VH repertoire.
@nl
prefLabel
The human immunoglobulin VH repertoire.
@ast
The human immunoglobulin VH repertoire.
@en
The human immunoglobulin VH repertoire.
@nl
P1433
P1476
The human immunoglobulin VH repertoire.
@en
P2093
P304
P356
10.1016/0167-5699(95)80166-9
P577
1995-05-01T00:00:00Z